Spinally delivered N-, P/Q- and L-type Ca2+-channel blockers potentiate morphine analgesia in mice

Tadaoki Fukuizumi1, Tsuyako Ohkubo, Kenji Kitamura

  • 1Department of Physiological Science and Molecular Biology, Fukuoka Dental College, 2-15-1 Tamura, Sawara, Fukuoka 814-0193, Japan.

Life Sciences
|September 27, 2003
PubMed

Insights

Combining spinal voltage-dependent calcium channel (VDCC) blockers with morphine enhances pain relief. Specifically, N- and P/Q-type VDCC blockers significantly boosted morphine

Area of Science:

  • Neuroscience
  • Pharmacology
  • Pain Research

Background:

  • Voltage-dependent calcium channels (VDCCs) play a crucial role in pain signaling at the spinal level.
  • Morphine is a primary analgesic, but its efficacy can be limited by side effects and tolerance.

Purpose of the Study:

  • To investigate the antinociceptive effects of spinal N-, P/Q-, and L-type VDCC blockers, alone and in combination with morphine.
  • To determine if VDCC blockers can potentiate morphine's analgesic effects and potentially reduce required morphine dosage.

Main Methods:

  • Intrathecal administration of omega-agatoxin IVA (P/Q-type), omega-conotoxin GVIA (N-type), and calciseptine (L-type) VDCC blockers in mice.
  • Assessment of antinociception using tail-flick (thermal) and tail-pressure (mechanical) tests.
  • Evaluation of the combined effects of subthreshold doses of VDCC blockers with morphine.

Main Results:

  • Intrathecal omega-agatoxin IVA and omega-conotoxin GVIA demonstrated potent dose-dependent antinociception against both thermal and mechanical stimuli.
  • Omega-conotoxin GVIA showed stronger antinociception against mechanical stimuli compared to thermal stimuli.
  • Subthreshold doses of N- and P/Q-type VDCC blockers significantly enhanced morphine analgesia, with a potency order of N- or P/Q-type greater than or equal to L-type.

Conclusions:

  • Spinal N- and P/Q-type VDCC blockers exhibit significant antinociceptive properties.
  • Combining low doses of N- or P/Q-type VDCC blockers with morphine offers a promising strategy for potentiating analgesia.
  • This combination approach may allow for reduced morphine dosage, potentially mitigating associated side effects.

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Local Anesthetics: Differential Sensitivity of Nerve Fibers01:24

Local Anesthetics: Differential Sensitivity of Nerve Fibers

Local anesthetics (LAs) block the sodium channels of nerve trunks, sensory nerve endings, and neuromuscular junctions. Although LAs can block all kinds of nerves, the sensitivity of nerve fibers differs according to nerve types and structures. LAs are known to block myelinated fibers faster than unmyelinated ones. Also, they block pain or sensory neurons at low concentrations without affecting the motor neurons involved in muscle contractions. This helps relieve labor pain without affecting the...
Local Anesthetics: Clinical Application as Spinal Anesthesia01:11

Local Anesthetics: Clinical Application as Spinal Anesthesia

Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...